Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsPaul W. Noble, Roland M. du Bois, Carlo Albera et al.|The Lancet|2011Cited by 2.1k
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trialTalmadge E. King, Roland M. du Bois, Carlo Albera et al.|The Lancet|2009Cited by 530
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important DifferenceRoland M. du Bois, Athol U. Wells, Carlo Albera et al.|American Journal of Respiratory and Critical Care Medicine|2011Cited by 523
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W. Noble, Talmadge E. King, Carlo Albera et al.|European Respiratory Journal|2015Cited by 462
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis: Test Validation and Minimal Clinically Important DifferenceRoland M. du Bois, Talmadge E. King, Derek Weycker et al.|American Journal of Respiratory and Critical Care Medicine|2010Cited by 457